Paul Mehan

679 total citations
10 papers, 463 citations indexed

About

Paul Mehan is a scholar working on Molecular Biology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Mehan has authored 10 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Otorhinolaryngology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Mehan's work include Head and Neck Cancer Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Paul Mehan is often cited by papers focused on Head and Neck Cancer Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Paul Mehan collaborates with scholars based in United States and Egypt. Paul Mehan's co-authors include Rakesh Gaur, Tara Elisabeth Seery, Jill Lacy, Sunil R. Hingorani, Shannon McDonough, Jeremy Kortmansky, Deepti Behl, Anthony F. Shields, Ramesh K. Ramanathan and Katherine A. Guthrie and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Paul Mehan

10 papers receiving 459 citations

Peers

Paul Mehan
Huangming Hong China
Kristie Lawhorn United States
Paul Scorer United Kingdom
Claudio Dansky Ullmann United States
Sabarinath Vallath United Kingdom
Thomas A. Summers United States
Panteleimon Kountourakis Greece
Rupal Desai United States
Karin Mengele Germany
Yuhua Feng China
Huangming Hong China
Paul Mehan
Citations per year, relative to Paul Mehan Paul Mehan (= 1×) peers Huangming Hong

Countries citing papers authored by Paul Mehan

Since Specialization
Citations

This map shows the geographic impact of Paul Mehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Mehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Mehan more than expected).

Fields of papers citing papers by Paul Mehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Mehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Mehan. The network helps show where Paul Mehan may publish in the future.

Co-authorship network of co-authors of Paul Mehan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Mehan. A scholar is included among the top collaborators of Paul Mehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Mehan. Paul Mehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Sadigh, Gelareh, Fenghai Duan, Na An, et al.. (2024). Financial Hardship Among Patients With Early-Stage Colorectal Cancer. JAMA Network Open. 7(9). e2431967–e2431967. 2 indexed citations
2.
Kircher, Sheetal, Fenghai Duan, Na An, et al.. (2024). Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer. JAMA Network Open. 7(1). e2350844–e2350844. 11 indexed citations
3.
Morris, Michael J., Glenn Heller, Alan H. Bryce, et al.. (2019). Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 37(15_suppl). 5008–5008. 33 indexed citations
4.
Ramanathan, Ramesh K., Shannon McDonough, Philip A. Philip, et al.. (2019). Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313. Journal of Clinical Oncology. 37(13). 1062–1069. 241 indexed citations
5.
6.
Adkins, Douglas R., Paul Mehan, Jessica Ley, et al.. (2018). Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study. The Lancet Oncology. 19(8). 1082–1093. 21 indexed citations
7.
Ley, Jessica, Paul Mehan, Tanya M. Wildes, et al.. (2013). Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Oncology. 85(5). 290–296. 42 indexed citations
8.
9.
Ramsingh, Giridharan, Paul Mehan, Jingqin Luo, Ravi Vij, & Daniel Morgensztern. (2009). Primary plasma cell leukemia. Cancer. 115(24). 5734–5739. 56 indexed citations
10.
Ramsingh, Giridharan, Paul Mehan, Jingqin Luo, Ravi Vij, & Daniel Morgensztern. (2009). Plasma cell leukemia: A SEER database analysis. Journal of Clinical Oncology. 27(15_suppl). 8605–8605. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huangming Hong Breakdown of academic impact, for papers by Kristie Lawhorn Breakdown of academic impact, for papers by Paul Scorer Breakdown of academic impact, for papers by Claudio Dansky Ullmann Breakdown of academic impact, for papers by Sabarinath Vallath Breakdown of academic impact, for papers by Thomas A. Summers Breakdown of academic impact, for papers by Panteleimon Kountourakis Breakdown of academic impact, for papers by Rupal Desai Breakdown of academic impact, for papers by Karin Mengele Breakdown of academic impact, for papers by Yuhua Feng
Rankless by CCL
2026